Lupus patients are not getting sick from CCP virus

ids said:
From https://www.sermo.com

Globally 17% Point Increase in COVID Treaters Who Have Used Hydroxychloroquine (33%-50%) and Azithromycin (41%-58%)

Percentage of New York Physicians Who Have Used Hydroxychloroquine Nearly Doubled, Italian and French Physicians Jumped 30% Points + Over 2 Weeks

Plasma Still Perceived as Most Effective but Not Widely Used

Perception of Hydroxychloroquine’s Efficacy is Significantly Higher Among Physicians in Europe and China vs US Physicians (50% vs 29%)
More...

The only reason doctors are using hydroxychloroquine is because it is widely available and cheap -- -and doctor's don't really have any other options available in most countries. So, yes, the use of hydroxychloroquine has increased; doctors might as well try it when the only other option is giving the patients tylenol.

However, day after day, as more study information comes out it is becoming clear that hydroxychloroquine based therapies for COVID-19 are probably not effective. It should be noted that both India and South Korea have guided doctors not to use hydroxychloroquine on COVID-19 patients since there is no proof that it is effective.

The recent reports about resdemisvir which lifted the market do not really prove the drug is effective for COVID-19 -- it only shows that one small trial showed positive result. Much more study is needed. Nor is resdemisvir widely available around the world. Gilead could only dig up 1700 doses to be used on a compassionate use basis for COVID-19 testing.

The reality is that it is likely that NO drug will be effective against COVID-19. Plasma will help but is not a definitive cure. Until a vaccine is developed and widely available we will be living under the "new normal".
 
TreeFrogTrader said:
There is a reason why Gilead's stock spiked based on leaked data results. The fact that the article speculated that it may not have "overwhelming efficacy" is neither here nor there. As I have said- probably close to six times now- this will be a game of stacking small edges together to improve treatment outcomes so any drug that can contribute to that will be seen as having potentiel. Those who are looking for a knock-out drug or cure will see no value.

Meanwhile. I have said that I will follow resdemisvir along with several other developments and I see no reason to not to that or to be less optimistic about resdemisivar. So far it shows an edge- although not overwhelmingly major. I am following hydroxy/ zpac as well and it's data is rather shaky- despite your advocacy for it- and that is fine. If it presents a valuable edge I will continue to look at it as the studies unfold. If it does not. Well, then fortunately there are several other developments. I am not married to anything.
More...
That's a reasonable posture. Unlike all the shit we hear from our TDS residents.
 
This is a great video explaining why the recent study that the media used for article to state that hydroxychlorquine is complete junk. It is just disgusting how democrats have tuned this into a political attack.

 
gwb-trading said:
The only reason doctors are using hydroxychloroquine is because it is widely available and cheap -- -and doctor's don't really have any other options available in most countries. So, yes, the use of hydroxychloroquine has increased; doctors might as well try it when the only other option is giving the patients tylenol.

However, day after day, as more study information comes out it is becoming clear that hydroxychloroquine based therapies for COVID-19 are probably not effective. It should be noted that both India and South Korea have guided doctors not to use hydroxychloroquine on COVID-19 patients since there is no proof that it is effective.

The recent reports about resdemisvir which lifted the market do not really prove the drug is effective for COVID-19 -- it only shows that one small trial showed positive result. Much more study is needed. Nor is resdemisvir widely available around the world. Gilead could only dig up 1700 doses to be used on a compassionate use basis for COVID-19 testing.

The reality is that it is likely that NO drug will be effective against COVID-19. Plasma will help but is not a definitive cure. Until a vaccine is developed and widely available we will be living under the "new normal".
More...
Well, according to this doctor, hydroxycholoquine with zpak does work. His results are below. He has documented a 0.5% mortality rate of patients that have gone to the hospital not of and estimate of total infected.

Watch the video above. I would like to hear your thoughts.


hydro-Copy.jpg
 
Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
https://www.henryford.com/news/2020/07/hydro-treatment-study
DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.


In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.
 
Last edited:
Buy1Sell2 said:
Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
https://www.henryford.com/news/2020/07/hydro-treatment-study
DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.


In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.

The study was published today in the International Journal of Infectious
More...
Summary of above study from another thread:
WeToddDid2 said:
  • Neither drug 26.4% mortality
  • Hydroxychloroquine alone 13.5% mortality
  • Hydroxychloroquine + azithromycin 20.1% mortality
  • Hydroxychloroquine provided a 66% hazard ratio reduction
  • Hydroxychloroquine + azithromycin 71% hazard ratio reduction
  • p < 0.001
More...
 
You must log in or register to reply here.
Back
Top